“It’s like ‘liquid handcuffs”: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients’ lives

• Published in: Harm reduction journal Vol. 18; no. 1; pp. 88 - 10
• Main Authors: Frank, David, Mateu-Gelabert, Pedro, Perlman, David C., Walters, Suzan M., Curran, Laura, Guarino, Honoria
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 14.08.2021; BioMed Central; BMC
• Subjects: Clinics; Coronaviruses; COVID-19; Disease transmission; Dosage; Drug dosages; Drug use; Harm reduction; HIV; Human immunodeficiency virus; Humans; Maintenance; Marginalized groups; Medical research; Methadone; Methadone - therapeutic use; Methadone clinics; Methadone maintenance; Methadone Maintenance Treatment (MMT); Methods; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders - drug therapy; Opioids; Overdose; Patient outcomes; Patient satisfaction; Patients; Patients’ rights; Policies; Policy; Public health; Retention; Risk management; Risk reduction; Stigma; Substance use; Take-home doses; Trauma; United States; United States > US; New York City New York; Harm reduction; Methadone Maintenance Treatment (MMT); Patients’ rights; Methadone clinics; Stigma; Take-home doses

Methadone Maintenance Treatment (MMT) is widely recognized as one of the most effective ways of reducing risk of overdose, arrest, and transmission of blood-borne viruses like HIV and HCV among people that use opioids. Yet, MMT's use of restrictive take-home dose policies that force most patien...